共 181 条
[11]
MacDonald R(2005)Measuring the effects of COPD on the patient Respir Med 99 S11-S18
[12]
Shekelle P(1984)The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest 85 751-758
[13]
Mahler DA(2003)Meaningful effect size and patterns of response of the transition dyspnea index J Clin Epidemiol 56 248-255
[14]
Selecky PA(2003)Minimal important difference of the transition dyspnea index in a multinational clinical trial Eur Respir J 21 267-272
[15]
Harrod CG(2005)The MCID of the transition dyspnea index is a total score of one unit COPD 2 99-103
[16]
Benditt JO(1986)Meta-analysis in clinical trials Contr Clin Trials 7 177-188
[17]
Carrieri-Kohlman V(1996)Understanding research synthesis (meta-analysis) Annu Rev Publ Health 17 1-23
[18]
Curtis JR(2007)Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis Arch Intern Med 167 335-342
[19]
Manning HL(2010)Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design Pulm Pharmacol Ther 23 165-171
[20]
Mularski RA(2010)Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium Respir Res 11 135-1876